Released Feb 27, 2017, after the close
10-K filed Feb 27, 2017, 58 days after period end · 0001564590-17-002569
Q4 2016 · 10-K
Revenue$108.54M$108.54M +3.7% vs Q4 2015+10.2% vs Q3 2016
Net Income-$3.24M-$3.24M N/M vs Q4 2015N/M vs Q3 2016
EPS Diluted-$0.18-$0.18 N/M vs Q4 2015N/M vs Q3 2016
Gross Profit$85,217,000+2.4%
Operating Income$7,416,000+0.5%
Operating Cash Flowderived$20,680,000+21.1%
Free Cash Flowderived$17,182,000+58.3%
Margins · derived
Gross margin78.5%−1.0 pt vs Q4 2015
Operating margin6.8%−0.2 pt vs Q4 2015
Net margin-3.0%−6.2 pt vs Q4 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $108.54M | $104.62M | $100.28M | $105.89M |
| Net Income | -$3.24M | $3.37M | -$5.80M | -$10.41M |
| EPS Diluted | -$0.18 | $0.18 | -$0.31 | -$0.58 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR